Navigation Links
Avastin Added to Chemo Helps Women With Advanced Breast Cancer
Date:5/31/2008

Anti-angiogenesis drug prolonged progression-free survival, study finds

SATURDAY, May 31 (HealthDay News) -- Adding the drug Avastin to chemotherapy lengthened progression-free survival in women with advanced breast cancer, new research shows.

Previous studies have found that adding Avastin (bevacizumab) to the chemotherapy drug Taxol (paclitaxel) in women with advanced breast cancer actually doubled progression-free survival.

Avastin is already approved for use in metastatic colon cancer, non-small cell lung cancer and, recently, in newly diagnosed metastatic breast cancer (in combination with paclitaxel).

"Avastin is an anti-angiogenesis drug [one that inhibits blood supply to the tumor] that appears to have activity across a variety of cancers," Dr. Nancy Davidson, director of the breast cancer program at Johns Hopkins Kimmel Cancer Center in Baltimore and president of the American Society of Clinical Oncology (ASCO), said during a teleconference earlier this month.

"Angiogenesis is clearly a very important process in the tumorogenesis of many malignances, and one of the first agents we've had available to us in the clinic is Avastin, which has demonstrated some efficacy in several genotypes," said study author Dr. David Miles, a medical oncologist at the Mount Vernon Cancer Centre in Middlesex, U.K.

Miles, who is presenting the findings this weekend at the American Society for Clinical Oncology annual meeting in Chicago, spoke at a Saturday news conference.

The current study looked at Avastin added to the chemotherapy agent Taxotere (docetaxel). Taxotere is more commonly used outside the United States, while Taxol is more commonly used in the United States.

This phase III trial involved 736 patients randomized into one of three groups: Taxotere alone, Taxotere plus a high dose (15 mg/kg) of Avastin, or Taxotere plus a low dose of Avastin (7.5 mg/kg). The lower dose of Ava
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Panel Says No to Avastin for Advanced Breast Cancer
2. Taxol with avastin produces noteworthy results
3. Many More Patients Can Now Benefit from Avastins Proven Survival Benefits
4. Despite Oncologists Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
5. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
6. FDA OKs Avastin for Advanced Breast Cancer
7. Off-Label Avastin Use for Wet Macular Degeneration
8. Avastin Added to Chemo Helps Women With Advanced Cancer
9. Corals added to IUCN Red List of Threatened Species for first time
10. Halozyme Therapeutics Added to Nasdaq Biotech Index
11. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Avastin Added to Chemo Helps Women With Advanced Breast Cancer
(Date:7/7/2015)... ... July 07, 2015 , ... ... announced the CelestixEdge VE and CelestixFederated VA Series virtual appliances. These virtual ... Series portfolio of products, which have proven to simplify the on-premises deployment of ...
(Date:7/7/2015)... ... ... end of June Pacific Prime Renewals team in Hong Kong announced that they were ... Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of paper ... anything between 300 and 600 pieces of paper per month. Not to mention A4 sized ...
(Date:7/7/2015)... ... , ... On Saturday, May 16th, 2015, the Manistee, MI chapter of the ... Best Drug Rehabilitation staff members were delighted to join in for this day of ... parent of the Manistee Kiwanis Club, is a global organization that works to bring ...
(Date:7/7/2015)... ... ... With a new community program in the San Antonio, TX area, Clear ... charity campaign to raise funds in support of programs for veterans. ‘May No Soldier ... to care for the special needs of our soldiers. Clear Insurance Group commences ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... as the company’s new Chief Financial Officer, effective July 6th, 2015. Ellen joins ... companies ranging from a multi-billion dollar, global chemical company to early and growth-stage ...
Breaking Medicine News(10 mins):Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3Health News:Office Practicum Announces new CFO 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced the approval of the KS-Ni Preloaded Silicone ... , , The KS-Ni Preloaded Silicone IOL Injector ... silicone IOL through an incision size of 2.6 mm ...
... ... results of the clinical study that was performed using the Bariatric Advantage High Protein ... on Obesity (ECO). , ... Amsterdam, Holland (Vocus) June 17, 2009 -- Bariatric Advantage presented the results of ...
... ... choosing an alcohol rehab centre. , ... UK (PRWEB) June 17, 2009 -- Linwood Group announce that there is no doubt that a ... struggling with drink on the road to recovery. Having treatment in a residential rehab centre offers ...
... ... select group of leading cardiovascular disease centers in the United States exploring the efficacy ... for the treatment of patients with advanced congestive heart failure (CHF) who are on ... ...
... says new leader of American medicine , , CHICAGO, ... from Bryan, Texas, was inaugurated today as the 164th president ... most influential physician organization. , , (Logo: ... his inaugural address as AMA president, Dr. Rohack spoke to ...
... and Philadelphia Business Journal to sponsor and present health ... Americans spend more than half of their ... many employers are looking for ways to help stem the increases ... Business Journal, Independence Blue Cross (IBC) is urging area business leaders ...
Cached Medicine News:Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 2Health News:STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System 3Health News:Bariatric Advantage High Protein Meal Replacement Clinical Study Presented at European Congress on Obesity 2Health News:Linwood Group Research Suggests 3 Questions Everyone Should Ask When Choosing an Alcoholic Residential Centre 2Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 2Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 3Health News:AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure 4Health News:AMA Inaugurates J. James Rohack as President 2Health News:Employee Health and Reducing Health Care Costs Focus of Working Wellness Expo June 17 2Health News:Employee Health and Reducing Health Care Costs Focus of Working Wellness Expo June 17 3
(Date:7/7/2015)... , June 30, 2015 ... ) has announced the addition of the ... report to their offering. This ... biomedicine. Photoacoustic imaging is a safe, non-invasive, ... advantages and represents a great alternative to ...
(Date:7/7/2015)... VIEJO, Calif. , July 7, 2015 /PRNewswire/ ... company focused on developing innovative devices for the ... R. Michael Kleine has joined its Board ... over 25 years of medical device and healthcare ... biomedical companies where he has commercialized numerous leading-edge ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 2Worldwide Biomedical Photoacoustic Imaging Patent Landscape Report 2015 3Sequent Medical Appoints Mike Kleine to its Board of Directors 2Sequent Medical Appoints Mike Kleine to its Board of Directors 3Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), ... the U.S. Food and Drug Administration (FDA) has approved ... and Mitigation Strategy) Access program. This new REMS is ... ABSTRAL ® (fentanyl) sublingual tablets, an ...
... 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. ... pharmaceutical company that specializes in patented biopharmaceutical ... and active pharmaceutical ingredients (API) today announced ... Chengdu Tianyin Pharmaceutical Co., Ltd,s ("Chengdu Tianyin") ...
Cached Medicine Technology:FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 2FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 3FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 4FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 5FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments 6TPI Receives Approval for High Tech Enterprise Status 2
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
... uncuffed endotracheal tubes are available ... in standard or precut lengths., ... pediatric uncuffed endotracheal tubes are ... with a radiopaque blue line ...
... Line® uncuffed endotracheal tubes are ... styles, in standard or precut ... and pediatric uncuffed endotracheal tubes ... chloride with a radiopaque blue ...
Medicine Products: